Clinical Trial Update: Cross-over Study of the Efficacy and Safety of SierraSil Joint Formula 14 in Osteoarthritis of the Knee [Phase 2]

View source ↗

Summary

The document reports the completion of a Phase 2 crossover trial evaluating the efficacy and safety of SierraSil Joint Formula 14 in knee osteoarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• SierraSil Joint Formula 14

Snippet

Sponsor: KGK Science Inc. | Conditions: Osteoarthritis of the Knee | Phase 2 | Status: COMPLETED